Sanofi (SNYNF) Receivables (2009 - 2026)

Sanofi (SNYNF) has 18 years of Receivables data on file, last reported at $27.5 billion in Q1 2026.

• Quarterly Receivables rose 19.72% year-over-year to $27.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.5 billion (up 19.72% YoY) and the FY2025 annual result came in at $27.1 billion, up 222.57% from the prior year.
• Receivables advanced to $27.5 billion in Q1 2026 per SNYNF's latest filing, from $27.1 billion in the prior quarter.
• The five-year high for Receivables was $28.6 billion in Q3 2025, with the low at $8.4 billion in Q2 2022.
• Average Receivables over 5 years is $15.4 billion, with a median of $9.2 billion recorded in 2024.
• Year-over-year, Receivables slipped 20.99% in 2024 and soared 222.57% in 2025.
• Sanofi's Receivables stood at $8.9 billion in 2022, then increased by 19.04% to $10.6 billion in 2023, then fell by 20.99% to $8.4 billion in 2024, then soared by 222.57% to $27.1 billion in 2025, then increased by 1.55% to $27.5 billion in 2026.
• Business Quant data shows SNYNF's Receivables at $27.5 billion in Q1 2026, $27.1 billion in Q4 2025, and $28.6 billion in Q3 2025.